News Ranibizumab vs Bevacizumab: Findings From the IVAN Trial by Medscape • 2012/12/17 • 0 Comments One-year results are in for the IVAN trial comparing ranibizumab with bevacizumab for the treatment of neovascular age-related macular degeneration. Medscape Ophthalmology Full Story →